GETWAB

02 / Federal Business Size

Federal contract market at a glance

Measured consistently across FY 2019–FY 2025.

Net obligations$212.03M
Contract actions27
Awards / PIIDs8
Federal customers1
Contracting offices2
Average action$7.85M
Active fiscal years6
Data coverageFY 2019–FY 2025

Across FY 2019–FY 2025, FPDS records attribute $212.03M in net contract obligations to PARTNER THERAPEUTICS, INC. across 27 contract actions. Net obligations include positive obligations and later deobligations recorded during the same period.

03 / Spending Trend

PARTNER THERAPEUTICS, INC. contract spending by year

Annual net obligations show whether recorded federal business expanded or contracted, while actions and customer counts show the breadth of that activity.

Total obligations$39.11M
FY 2025
ObligationsHistorical spending range
Fiscal yearObligationsActionsFederal customersChange
FY 2019$55.00M11
FY 2021$751.1K21−98.6%
FY 2022$59.03M51+7,758.5%
FY 2023$22.95M51−61.1%
FY 2024$35.19M61+53.4%
FY 2025$39.11M81+11.1%

04 / Federal Customers

Which federal agencies buy from PARTNER THERAPEUTICS, INC.?

Ranked by net obligations during FY 2019–FY 2025.

AgencyCodeObligationsActionsVendor share
7505$212.03M27100.0%

05 / Contracting Offices

Which contracting offices buy from PARTNER THERAPEUTICS, INC.?

Ranked by net obligations during FY 2019–FY 2025.

06 / Top NAICS Industries

Which industries define this vendor’s federal work?

NAICSDescriptionObligationsActionsCustomersShare
325412PHARMACEUTICAL PREPARATION MANUFACTURING$197.54M13193.2%
541715RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)$12.99M416.1%
541714RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)$1.50M810.7%
325414BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING$2.2K210.0%

07 / Top Product and Service Codes

What products and services does the government buy from this vendor?

PSCDescriptionObligationsActionsCustomersShare
6515MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES$83.52M6139.4%
6505DRUGS AND BIOLOGICALS$59.03M5127.8%
3650CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY$55.00M2125.9%
AN13HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT$13.74M1116.5%
AN15HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPENSES FOR R&D FACILITIES AND MAJOR EQUIPMENT$748.0K310.4%

08 / Competition Pattern

How was PARTNER THERAPEUTICS, INC.’s federal work competed?

Competition categories describe the procurement path recorded on the underlying contract actions.

Competition categoryObligationsActions
Competed$144.04M21
Competed under SAP$12.99M4
Other / unknown$55.00M2

09 / Recent Contract Awards

What contract actions were recorded most recently for PARTNER THERAPEUTICS, INC.?

The latest recorded PIIDs connect this profile to the underlying federal award search.

Award / PIIDSignedObligationAgency / officeNAICSPSC
75A50323F80027Sep 8, 2025$0ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE ASPR/ORM-SNS3254126515

10 / Interpreting the Profile

How should you evaluate PARTNER THERAPEUTICS, INC. as a federal contractor?

Read obligations, customers, markets, competition, and individual awards together. A large historical total indicates federal scale, but it does not by itself describe current backlog, commercial revenue, profitability, or future opportunity.

01

Separate obligations from revenue

FPDS obligations are government accounting actions and may include later deobligations.

02

Follow customer concentration

Agency and office concentration reveals where the vendor’s federal relationships are strongest.

03

Test market overlap

NAICS and PSC shares show whether the vendor competes in the same markets as your company.

04

Inspect the awards

Open the PIIDs to verify dates, offices, classifications, and transaction history.